Primary Mitochondrial Myopathy
5 clinical trials · Condition
◉ Watch Primary Mitochondrial Myopathy
| Record | Firm | Date |
|---|---|---|
| An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead) (NCT05267574) | Reneo Pharma Ltd | 2022-02-01 |
| A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy (NCT04641962) | Astellas Pharma Inc | 2021-05-24 |
| An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients (NCT04535609) | Reneo Pharma Ltd | 2021-05-21 |
| A Study of the Safety of REN001 in Patients With Primary Mitochondrial Myopathy (NCT03862846) | Reneo Pharma Ltd | 2019-05-10 |
| A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension (NCT03323749) | Stealth BioTherapeutics Inc. | 2017-10-09 |
Track Primary Mitochondrial Myopathy automatically
Every clearance here is in the API, with alerts when new ones post.